Evidence map›Paper›PMID 37257028›Full record

ArticleDiabetes2024

β-Cell Function and Insulin Dynamics in Obese Patients With and Without Diabetes After Sleeve Gastrectomy.

Xin Huang, Yian Zhao, Teng Liu, Dong Wu, Jiaxin Shu, Wenwen Yue, Wenjing Zhang, Shaozhuang Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xin HuangDivision of Bariatric and Metabolic Surgery, Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Yian ZhaoSchool of Clinical Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
Teng LiuDivision of Bariatric and Metabolic Surgery, Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Dong WuDivision of Pancreatic Surgery, Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.
Jiaxin ShuSchool of Clinical Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wenwen YueSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wenjing ZhangSchool of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
Shaozhuang LiuDivision of Bariatric and Metabolic Surgery, Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.ORCID 0000-0003-2052-0516
Qilu Hospital of Shandong University · CNShandong University · CN

Funding

Bethune Charitable Foundation HZB-20190528-9Clinical Research Project of Shandong University 2020SDUCRCC024National Natural Science Foundation of China 82100853Natural Science Foundation of Shandong Province ZR2021QH028
6 · The paper itself

Abstract

Improved β-cell function seems to be essential for better glucose homeostasis after Roux-en-Y gastric bypass but is less studied after sleeve gastrectomy (SG). We evaluated the effects of SG on β-cell function in obese patients with diabetes (DM group) and without (control group) in response to both oral and intravenous glucose stimulation. The DM group demonstrated impaired insulin sensitivity and insulin response to glucose before surgery. The insulin sensitivity index of both groups significantly improved after SG. In addition, the insulin response to glucose (early insulinogenic index in oral glucose tolerance test and acute insulin response to glucose in an intravenous glucose tolerance test) increased in the DM group but decreased in the control group. As a result, β-cell function improved significantly in both groups after SG since the disposition index (DI) increased in both. However, the DI of the DM group was not restored to the level of control group up to 1 year after SG. Our results support that obese patients, with and without diabetes, could benefit from SG in β-cell function. For obese patients at risk for or who have been diagnosed with diabetes, interventions should be recommended early to preserve or restore β-cell function, and SG could be an effective choice. Further studies are needed for long-term effects. ARTICLE HIGHLIGHTS:

Indexed as

Diabetes Mellitus, Type 2Gastric BypassInsulin ResistanceObesity, MorbidBlood GlucoseGastrectomyGlucoseHumansInsulinInsulin, Regular, HumanObesityBlood GlucoseGlucoseInsulinInsulin, Regular, Human

Identifiers

PMID37257028
OpenAlexW4378802381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.